Opinion 10 Nov 2021 Automation Can Solve Diversity Issues in Clinical Trial Recruitment …morning, while some younger people prefer to receive texts in the afternoon. We are working on a study with Queen Mary University of London in Parkinson’s disease, where diabetes is… November 10, 2021 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 16 Nov 2017 Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics …in oncology: “At the moment, I’m very committed to the fight against cancer, but there’s an enormous amount of other very challenging diseases… like Alzheimer’s, Parkinson’s disease… and rare diseases…… November 16, 2017 - 6 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jun 2023 AbbVie takes step forward in Europe with migraine drug …aims to democratize medicine by developing affordable vaccines for chronic conditions such as migraines, Alzheimer’s and Parkinson’s — to name a few. By combining the power of mAbs and the… June 26, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sector A – Z Index …mRNA technology Multiple myeloma Multiple sclerosis Muscular dystrophy N Nanotechnology NASH Neurodegenerative disease Neurological disorders Next generation sequencing O Obesity omics Organoids Organs-on-chips osteoarthritis P Parkinson’s Peptides Phage therapy Precision… March 24, 2023 - 0 minutesmins - By Developer Share WhatsApp Twitter Linkedin Email
More News! 18 Feb 2019 Enormous Series A to Help Bring Epilepsy Drug to Market …Axovant’s small molecule operations. Axovant will now focus on developing the gene therapies in its pipeline, including for Parkinson’s Disease, and the rare disease GM1 gangliosidosis. While being pretty impressive,… February 18, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Jun 2024 5 companies spearheading the emerging biotech scene in the Balkans …development of novel, proprietary, blood-brain barrier permeable small molecules for the treatment of neuroinflammatory and neurodegenerative diseases, such as diabetic retinopathy, demyelination and multiple sclerosis (MS), Parkinson’s and Alzheimer’s disease. … June 18, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 15 Aug 2022 Aptinyx fibromyalgia drug misses endpoint …cognitive impairment associated with Parkinson’s disease, expected in the first quarter of next year.” Study details The fibromyalgia study was a randomized, double-blind, placebo-controlled study designed to evaluate the efficacy… August 15, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Nov 2019 €51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics …cancer and Parkinson’s disease. Centogen has attracted high investor interest in the past, raising a Series A round of €25M in 2017. However, according to an analyst on Seeking Alpha,… November 7, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2020 Investment Is Pouring Into Neuromodulation Treatments …hearing-impaired patients, and the motor symptoms of Parkinson’s disease can sometimes be treated by electrically activating neurons deep in the brain. With advances in computational technology, these devices are getting… October 7, 2020 - 6 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 20 Jun 2025 Stem cell therapy: a potential cure for hearing loss? …transform into brain cells and regulate dopamine levels to relieve some of the motor symptoms of Parkinson’s disease – being investigated through ongoing clinical trials – has evidenced the competence… June 20, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Jun 2020 How Personal Genomics Companies Are Changing Drug Development …thousands of patients with Parkinson’s disease in partnership with Genentech. They achieved this in record time compared to usual prospective biobanking studies requiring regulatory approval. Some companies are proposing a… June 1, 2020 - 6 minutesmins - By Timothé Cynober Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2022 Cancer Research UK Deploys €700M to Foster Oncology Startups …number of research charities already work with scientists to develop disease treatments, such as a virtual biotech system employed by Parkinson’s UK. CRUK hopes to see more of this activity… April 27, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email